TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 252 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $246 | +16.6% | 13,872 | -0.3% | 0.26% | +2.0% |
| Q1 2024 | $211 | -14.2% | 13,911 | -3.1% | 0.25% | -19.4% |
| Q4 2023 | $246 | -99.8% | 14,356 | +1.1% | 0.32% | +94.4% |
| Q3 2023 | $118,670 | -61.3% | 14,195 | +15.1% | 0.16% | -60.9% |
| Q2 2023 | $306,401 | +117746.5% | 12,335 | -28.6% | 0.41% | +7.8% |
| Q1 2023 | $260 | +23.2% | 17,276 | -3.1% | 0.38% | +58.7% |
| Q4 2022 | $211 | -99.8% | 17,826 | +3.6% | 0.24% | +126.2% |
| Q3 2022 | $102,000 | -28.7% | 17,204 | +14.6% | 0.11% | +1.9% |
| Q1 2022 | $143,000 | -50.0% | 15,018 | -0.3% | 0.10% | -45.3% |
| Q4 2021 | $286,000 | -43.4% | 15,062 | -0.7% | 0.19% | -50.6% |
| Q3 2021 | $505,000 | -13.4% | 15,175 | +1.0% | 0.39% | -14.9% |
| Q2 2021 | $583,000 | -19.3% | 15,029 | +0.3% | 0.46% | -25.2% |
| Q1 2021 | $722,000 | +862.7% | 14,984 | -15.0% | 0.61% | +426.7% |
| Q2 2020 | $75,000 | – | 17,628 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
| Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
| RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
| Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
| Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
| ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
| Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
| ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
| Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |